Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,313,684
-
Share change
-
+289,755
-
Total reported value
-
$46,330,666
-
Price per share
-
$2.84
-
Number of holders
-
41
-
Value change
-
+$1,003,639
-
Number of buys
-
21
-
Number of sells
-
18
Institutional Holders of CYTEIR THERAPEUTICS INC - COM (CYTT) as of Q3 2023
As of 30 Sep 2023,
CYTEIR THERAPEUTICS INC - COM (CYTT) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,313,684 shares.
The largest 10 holders included
BML Capital Management, LLC, Newtyn Management, LLC, OUP Management Co., LLC, Anson Funds Management LP, VR Advisory Services Ltd, FMR LLC, Novo Holdings A/S, VANGUARD GROUP INC, GABELLI FUNDS LLC, and GABELLI & Co INVESTMENT ADVISERS, INC..
This page lists
41
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.